Traditionally, scientists believed that obesity led to type 2 diabetes by impairing insulin signaling within liver and fat ...

The long-term consequences of this metabolic dysfunction are extensive. (Image Credits: Pixabay) Diabetes risk and obesity: ...

A new joint study by the University of Eastern Finland and Karolinska Institutet in Sweden found that the GLP-1 agonists semaglutide and liraglutide, which are used for treating diabetes and obesity, ...

Know about diabetes day in Hindi on TheHealthSite.com, Explore diabetes day with Articles, Photos, Video, न्यूज़, ताज़ा ख़बर in Hindi with TheHealthSite.com ...

Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or ...

Monogenic forms of early onset severe childhood obesity (ie, presenting before the age of 5 years) can occur in the context ...

The blockbuster drugs Ozempic and Wegovy may help people cut back on drinking, new research published Wednesday in JAMA ...

Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible ...

Eli Lilly said new results from a Phase 3 study of its tirzepatide showed weekly injections in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss, with nearly 99% ...

More than 800 million adults have diabetes worldwide – almost twice as many as previous estimates have suggested – and more than half of those aged over 30 who have the condition are not receiving ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

Following an impressive data drop this summer highlighting the potential for Eli Lilly’s tirzepatide to stave off progression ...